News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
451,391 Results
Type
Article (28349)
Company Profile (62)
Press Release (422976)
Multimedia
Podcasts (146)
Webinars (16)
Section
Business (153219)
Career Advice (1576)
Deals (20611)
Drug Delivery (89)
Drug Development (47663)
Employer Resources (103)
FDA (10120)
Job Trends (9814)
News (219519)
Policy (20206)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1829)
Academic (2)
Accelerated approval (32)
ADA (32)
Adcomms (17)
Allergies (139)
Alliances (37750)
ALS (155)
Alzheimer's disease (1247)
Antibody-drug conjugate (ADC) (385)
Approvals (10578)
Artificial intelligence (568)
ASCO (235)
Autoimmune disease (258)
Automation (56)
Bankruptcy (179)
Best Places to Work (7803)
BIO (45)
BIOSECURE Act (8)
Biosimilars (166)
Biotechnology (50)
Bladder cancer (160)
Brain cancer (45)
Breast cancer (601)
Cancer (4707)
Cardiovascular disease (366)
Career advice (1374)
Career pathing (37)
CAR-T (230)
CDC (34)
Celiac Disease (2)
Cell therapy (697)
Cervical cancer (43)
Clinical research (42112)
Collaboration (1891)
Commercialization (1)
Company closure (6)
Compensation (492)
Complete response letters (42)
COVID-19 (1858)
CRISPR (86)
C-suite (810)
Cystic fibrosis (98)
Data (6526)
Decentralized trials (3)
Denatured (53)
Depression (118)
Dermatology (71)
Diabetes (478)
Diagnostics (5643)
Digital health (46)
Diversity (8)
Diversity, equity & inclusion (30)
Drug discovery (297)
Drug pricing (112)
Drug shortages (22)
Duchenne muscular dystrophy (224)
Earnings (64164)
Editorial (55)
Employer branding (14)
Employer resources (91)
Events (67601)
Executive appointments (752)
FDA (12986)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1240)
Gene editing (181)
Generative AI (55)
Gene therapy (571)
GLP-1 (766)
Government (3010)
Grass and pollen (7)
Guidances (364)
Healthcare (11489)
Hematology (133)
HIV (72)
Huntington's disease (43)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (82)
Immunology and inflammation (197)
Immuno-oncology (85)
Indications (173)
Infectious disease (2114)
Inflammatory bowel disease (156)
Inflation Reduction Act (14)
Influenza (100)
Intellectual property (224)
Interviews (280)
IPO (9375)
IRA (33)
Job creations (2290)
Job search strategy (1126)
JPM (47)
Kidney cancer (18)
Labor market (72)
Layoffs (313)
Leadership (34)
Legal (5005)
Liver cancer (62)
Longevity (25)
Lung cancer (617)
Lymphoma (371)
Machine learning (41)
Management (35)
Manufacturing (838)
Marketing (3)
MASH (165)
Medical affairs (1)
Medical device (7701)
Medtech (7802)
Mergers & acquisitions (12195)
Metabolic disorders (1174)
mRNA (151)
Multiple sclerosis (153)
NASH (10)
Neurodegenerative disease (320)
Neuropsychiatric disorders (72)
Neuroscience (2365)
NextGen: Class of 2026 (3897)
Non-profit (3036)
Now hiring (37)
Obesity (506)
Opinion (234)
Ovarian cancer (175)
Pain (173)
Pancreatic cancer (241)
Parkinson's disease (262)
Partnered (27)
Patents (429)
Patient recruitment (444)
Peanut (38)
People (36146)
Pharmaceutical (15)
Pharmacy benefit managers (19)
Phase 1 (12979)
Phase 2 (18024)
Phase 3 (14745)
Pipeline (7898)
Policy (198)
Postmarket research (1767)
Preclinical (5872)
Press Release (48)
Prostate cancer (292)
Psychedelics (38)
Radiopharmaceuticals (239)
Rare diseases (828)
Real estate (3865)
Recruiting (41)
Regulatory (16096)
Reports (31)
Research institute (1736)
Resumes & cover letters (236)
Rett syndrome (31)
RNA editing (16)
RSV (59)
Schizophrenia (131)
Series A (230)
Series B (136)
Service/supplier (2)
Sickle cell disease (94)
Special edition (15)
Spinal muscular atrophy (105)
Sponsored (34)
Startups (2095)
State (1)
Stomach cancer (12)
Supply chain (84)
Tariffs (40)
The Weekly (92)
Vaccines (763)
Venture capital (82)
Weight loss (318)
Women's health (92)
Worklife (16)
Date
Last 7 days (271)
Last 30 days (1222)
Last 365 days (21152)
2026 (11706)
2025 (20907)
2024 (22824)
2023 (25380)
2022 (32924)
2021 (35134)
2020 (34262)
2019 (28683)
2018 (21373)
2017 (20606)
2016 (20159)
2015 (22944)
2014 (19145)
2013 (16813)
2012 (17064)
2011 (16615)
2010 (15456)
Location
Africa (622)
Alabama (75)
Alaska (5)
Arizona (194)
Arkansas (9)
Asia (26226)
Australia (4373)
California (9565)
Canada (2747)
China (1013)
Colorado (441)
Connecticut (467)
Delaware (287)
Europe (61286)
Florida (1453)
Georgia (303)
Hawaii (3)
Idaho (29)
Illinois (739)
India (75)
Indiana (525)
Iowa (12)
Japan (432)
Kansas (97)
Kentucky (32)
Louisiana (33)
Maine (50)
Maryland (1104)
Massachusetts (6707)
Michigan (266)
Minnesota (411)
Mississippi (3)
Missouri (126)
Montana (18)
Nebraska (12)
Nevada (100)
New Hampshire (44)
New Jersey (2820)
New Mexico (18)
New York (2533)
North Carolina (1237)
North Dakota (6)
Northern California (4731)
Ohio (286)
Oklahoma (16)
Oregon (25)
Pennsylvania (1886)
Puerto Rico (14)
Rhode Island (34)
South America (851)
South Carolina (38)
Southern California (3935)
Tennessee (173)
Texas (1635)
United States (33861)
Utah (307)
Vermont (1)
Virginia (216)
Washington D.C. (57)
Washington State (739)
West Virginia (3)
Wisconsin (97)
Wyoming (2)
451,391 Results for "colossal laboratories and biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck
April 30, 2026
·
20 min read
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
·
11 min read
Press Releases
Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler
April 14, 2026
·
3 min read
Press Releases
Colossal Foundation Partners With University of Tasmania on Vaccines and Gene Editing to Fight Devil Facial Tumour Disease
July 1, 2026
·
3 min read
Press Releases
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
November 5, 2025
·
6 min read
Press Releases
World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer
August 21, 2025
·
5 min read
Lone Star Bio
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
Colossal Biosciences, the world’s first de-extinction company, announces that their Woolly Mammoth team has achieved a global-first iPSC breakthrough.
March 6, 2024
·
6 min read
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Press Releases
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth
March 5, 2025
·
6 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
·
4 min read
1 of 45,140
Next
